370 related articles for article (PubMed ID: 23622515)
21. Dual phosphorylation of the T-loop in cdk7: its role in controlling cyclin H binding and CAK activity.
Martinez AM; Afshar M; Martin F; Cavadore JC; Labbé JC; Dorée M
EMBO J; 1997 Jan; 16(2):343-54. PubMed ID: 9029154
[TBL] [Abstract][Full Text] [Related]
22. JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21.
Colleoni B; Paternot S; Pita JM; Bisteau X; Coulonval K; Davis RJ; Raspé E; Roger PP
Oncogene; 2017 Jul; 36(30):4349-4361. PubMed ID: 28368408
[TBL] [Abstract][Full Text] [Related]
23. Structural basis for CDK7 activation by MAT1 and Cyclin H.
Peissert S; Schlosser A; Kendel R; Kuper J; Kisker C
Proc Natl Acad Sci U S A; 2020 Oct; 117(43):26739-26748. PubMed ID: 33055219
[TBL] [Abstract][Full Text] [Related]
24. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ
Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031
[TBL] [Abstract][Full Text] [Related]
25. A Cdk4/6-dependent phosphorylation gradient regulates the early to late G1 phase transition.
Kaulich M; Link VM; Lapek JD; Lee YJ; Glass CK; Gonzalez DJ; Dowdy SF
Sci Rep; 2021 Jul; 11(1):14736. PubMed ID: 34282211
[TBL] [Abstract][Full Text] [Related]
26. Loss of CDK4/6 activity in S/G2 phase leads to cell cycle reversal.
Cornwell JA; Crncec A; Afifi MM; Tang K; Amin R; Cappell SD
Nature; 2023 Jul; 619(7969):363-370. PubMed ID: 37407814
[TBL] [Abstract][Full Text] [Related]
27. The proto-oncogene c-myc acts through the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) to facilitate the activation of Cdk4/6 and early G(1) phase progression.
Obaya AJ; Kotenko I; Cole MD; Sedivy JM
J Biol Chem; 2002 Aug; 277(34):31263-9. PubMed ID: 12070150
[TBL] [Abstract][Full Text] [Related]
28. Regulation of CDK7-carboxyl-terminal domain kinase activity by the tumor suppressor p16(INK4A) contributes to cell cycle regulation.
Nishiwaki E; Turner SL; Harju S; Miyazaki S; Kashiwagi M; Koh J; Serizawa H
Mol Cell Biol; 2000 Oct; 20(20):7726-34. PubMed ID: 11003668
[TBL] [Abstract][Full Text] [Related]
29. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
Santamaria D; Ortega S
Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase C inhibits the CAK-CDK2 cyclin-dependent kinase cascade and G1/S cell cycle progression in human diploid fibroblasts.
Hamada K; Takuwa N; Zhou W; Kumada M; Takuwa Y
Biochim Biophys Acta; 1996 Jan; 1310(1):149-56. PubMed ID: 9244189
[TBL] [Abstract][Full Text] [Related]
31. Retinoblastoma protein-overexpressing HL60 cells resistant to 1,25-dihydroxyvitamin D3 display increased CDK2 and CDK6 activity and shortened G1 phase.
Wang QM; Luo X; Kheir A; Coffman FD; Studzinski GP
Oncogene; 1998 May; 16(21):2729-37. PubMed ID: 9652739
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human astrocytoma cells by the pyrrolo-1,5-benzoxazepine, PBOX-21.
Mulligan JM; Campiani G; Ramunno A; Nacci V; Zisterer DM
Biochim Biophys Acta; 2003 Sep; 1639(1):43-52. PubMed ID: 12943967
[TBL] [Abstract][Full Text] [Related]
33. Cyclin D-Cdk4,6 Drives Cell-Cycle Progression via the Retinoblastoma Protein's C-Terminal Helix.
Topacio BR; Zatulovskiy E; Cristea S; Xie S; Tambo CS; Rubin SM; Sage J; Kõivomägi M; Skotheim JM
Mol Cell; 2019 May; 74(4):758-770.e4. PubMed ID: 30982746
[TBL] [Abstract][Full Text] [Related]
34. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity.
Clark W; Black EJ; MacLaren A; Kruse U; LaThangue N; Vogt PK; Gillespie DA
Mol Cell Biol; 2000 Apr; 20(7):2529-42. PubMed ID: 10713176
[TBL] [Abstract][Full Text] [Related]
35. CyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stability.
Dozier C; Mazzolini L; Cénac C; Froment C; Burlet-Schiltz O; Besson A; Manenti S
Oncogene; 2017 Jun; 36(26):3781-3788. PubMed ID: 28192398
[TBL] [Abstract][Full Text] [Related]
36. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
Chen WJ; Chang CY; Lin JK
Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
[TBL] [Abstract][Full Text] [Related]
37. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
[TBL] [Abstract][Full Text] [Related]
38. CAK-Cyclin-dependent Activating Kinase: a key kinase in cell cycle control and a target for drugs?
Lolli G; Johnson LN
Cell Cycle; 2005 Apr; 4(4):572-7. PubMed ID: 15876871
[TBL] [Abstract][Full Text] [Related]
39. Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro.
Takaki T; Fukasawa K; Suzuki-Takahashi I; Semba K; Kitagawa M; Taya Y; Hirai H
J Biochem; 2005 Mar; 137(3):381-6. PubMed ID: 15809340
[TBL] [Abstract][Full Text] [Related]
40. Novel properties of the cyclin encoded by Human Herpesvirus 8 that facilitate exit from quiescence.
Child ES; Mann DJ
Oncogene; 2001 Jun; 20(26):3311-22. PubMed ID: 11423981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
